These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

919 related items for PubMed ID: 19659944

  • 1. High rates of active hepatitis B and C co-infections in HIV-1 infected Cameroonian adults initiating antiretroviral therapy.
    Laurent C, Bourgeois A, Mpoudi-Ngolé E, Kouanfack C, Ciaffi L, Nkoué N, Mougnutou R, Calmy A, Koulla-Shiro S, Ducos J, Delaporte E.
    HIV Med; 2010 Jan; 11(1):85-9. PubMed ID: 19659944
    [Abstract] [Full Text] [Related]

  • 2. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
    Rai RR, Mathur A, Mathur D, Udawat HP, Nepalia S, Nijhawan S, Mathur A.
    Trop Gastroenterol; 2007 Jan; 28(1):19-23. PubMed ID: 17896605
    [Abstract] [Full Text] [Related]

  • 3. Predictors and kinetics of occult hepatitis B virus infection in HIV-infected persons.
    Nebbia G, Garcia-Diaz A, Ayliffe U, Smith C, Dervisevic S, Johnson M, Gilson R, Tedder R, Geretti AM.
    J Med Virol; 2007 Oct; 79(10):1464-71. PubMed ID: 17705185
    [Abstract] [Full Text] [Related]

  • 4. [Investigation of occult hepatitis B in HIV infected patients].
    Altınbaş A, Ergünay K, Calık Başaran N, Alp A, Turgut D, Hasçelik G, Uzun Ö, Unal S.
    Mikrobiyol Bul; 2011 Apr; 45(2):353-8. PubMed ID: 21644079
    [Abstract] [Full Text] [Related]

  • 5. Prevalence and impact of hepatitis B and C virus co-infections in antiretroviral treatment naïve patients with HIV infection at a major treatment center in Ghana.
    Sagoe KW, Agyei AA, Ziga F, Lartey M, Adiku TK, Seshi M, Arens MQ, Mingle JA.
    J Med Virol; 2012 Jan; 84(1):6-10. PubMed ID: 22095533
    [Abstract] [Full Text] [Related]

  • 6. Longitudinal evaluation of viral interactions in treated HIV-hepatitis B co-infected patients with additional hepatitis C and D virus.
    Boyd A, Lacombe K, Miailhes P, Gozlan J, Bonnard P, Molina JM, Lascoux-Combe C, Serfaty L, Gault E, Desvarieux M, Girard PM.
    J Viral Hepat; 2010 Jan; 17(1):65-76. PubMed ID: 19682317
    [Abstract] [Full Text] [Related]

  • 7. Occult hepatitis B virus infection in ART-naive HIV-infected patients seen at a tertiary care centre in north India.
    Gupta S, Singh S.
    BMC Infect Dis; 2010 Mar 07; 10():53. PubMed ID: 20205948
    [Abstract] [Full Text] [Related]

  • 8. HBV and HCV prevalence and viraemia in HIV-positive and HIV-negative pregnant women in Abidjan, Côte d'Ivoire: the ANRS 1236 study.
    Rouet F, Chaix ML, Inwoley A, Msellati P, Viho I, Combe P, Leroy V, Dabis F, Rouzioux C, ANRS 1236 DITRAME-B&C Study Group.
    J Med Virol; 2004 Sep 07; 74(1):34-40. PubMed ID: 15258966
    [Abstract] [Full Text] [Related]

  • 9. Impact of tenofovir-containing antiretroviral therapy on chronic hepatitis B in a cohort co-infected with human immunodeficiency virus.
    Stephan C, Berger A, Carlebach A, Lutz T, Bickel M, Klauke S, Staszewski S, Stuermer M.
    J Antimicrob Chemother; 2005 Dec 07; 56(6):1087-93. PubMed ID: 16269552
    [Abstract] [Full Text] [Related]

  • 10. Increased detection of HBV DNA in HBsAg-positive and HBsAg-negative South African HIV/AIDS patients enrolling for highly active antiretroviral therapy at a Tertiary Hospital.
    Lukhwareni A, Burnett RJ, Selabe SG, Mzileni MO, Mphahlele MJ.
    J Med Virol; 2009 Mar 07; 81(3):406-12. PubMed ID: 19152393
    [Abstract] [Full Text] [Related]

  • 11. Outcome of hepatitis B and C virus infection on graft function after renal transplantation.
    Behzad-Behbahani A, Mojiri A, Tabei SZ, Farhadi-Andarabi A, Pouransari R, Yaghobi R, Rahsaz M, Banihashemi M, Malek-Hosseini SA, Javid A, Bahador A, Reisjalali A, Behzadi S, Salehipour M, Salahl A, Davari R, Janghorban P, Torb A, Salah AR.
    Transplant Proc; 2005 Sep 07; 37(7):3045-7. PubMed ID: 16213299
    [Abstract] [Full Text] [Related]

  • 12. Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy.
    Sheng WH, Kao JH, Chen PJ, Huang LM, Chang SY, Sun HY, Hung CC, Chen MY, Chang SC.
    Clin Infect Dis; 2007 Nov 01; 45(9):1221-9. PubMed ID: 17918088
    [Abstract] [Full Text] [Related]

  • 13. Hepatitis B and C virus coinfection in The TREAT Asia HIV Observational Database.
    Zhou J, Dore GJ, Zhang F, Lim PL, Chen YM, TREAT Asia HIV Observational Database.
    J Gastroenterol Hepatol; 2007 Sep 01; 22(9):1510-8. PubMed ID: 17645479
    [Abstract] [Full Text] [Related]

  • 14. Hepatitis B, C seroprevalence and delta viruses in HIV-1 Senegalese patients at HAART initiation (retrospective study).
    Diop-Ndiaye H, Touré-Kane C, Etard JF, Lô G, Diaw P, Ngom-Gueye NF, Gueye PM, Ba-Fall K, Ndiaye I, Sow PS, Delaporte E, Mboup S.
    J Med Virol; 2008 Aug 01; 80(8):1332-6. PubMed ID: 18551596
    [Abstract] [Full Text] [Related]

  • 15. Molecular epidemiological and clinical aspects of hepatitis D virus in a unique triple hepatitis viruses (B, C, D) endemic community in Taiwan.
    Lu SN, Chen TM, Lee CM, Wang JH, Tung HD, Wu JC.
    J Med Virol; 2003 May 01; 70(1):74-80. PubMed ID: 12629646
    [Abstract] [Full Text] [Related]

  • 16. Seroprevalence of hepatitis B and C viruses among HIV-infected pregnant women in Uganda and Rwanda.
    Pirillo MF, Bassani L, Germinario EA, Mancini MG, Vyankandondera J, Okong P, Vella S, Giuliano M.
    J Med Virol; 2007 Dec 01; 79(12):1797-801. PubMed ID: 17935164
    [Abstract] [Full Text] [Related]

  • 17. HIV, hepatitis C virus, and hepatitis B virus co-infections among injecting drug users in Tehran, Iran.
    Rahimi-Movaghar A, Razaghi EM, Sahimi-Izadian E, Amin-Esmaeili M.
    Int J Infect Dis; 2010 Jan 01; 14(1):e28-33. PubMed ID: 19464218
    [Abstract] [Full Text] [Related]

  • 18. [Epidemiological and clinical features of occult hepatitis B in HIV infection without antiretroviral treatment].
    Zhang RF, Liu L, Zheng YF, Shen YZ, Chen J, Gu SM, Wang JR, Lu HZ.
    Zhonghua Gan Zang Bing Za Zhi; 2013 Mar 01; 21(3):189-91. PubMed ID: 23967739
    [Abstract] [Full Text] [Related]

  • 19. Occult hepatitis B virus infection in HIV-infected patients with isolated hepatitis B core antibody.
    Azadmanesh K, Mohraz M, Aghakhani A, Edalat R, Jam S, Eslamifar A, Banifazl M, Moradmand-Badie B, Ramezani A.
    Intervirology; 2008 Mar 01; 51(4):270-4. PubMed ID: 18841029
    [Abstract] [Full Text] [Related]

  • 20. Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapy.
    Cohen Stuart JW, Velema M, Schuurman R, Boucher CA, Hoepelman AI.
    J Med Virol; 2009 Mar 01; 81(3):441-5. PubMed ID: 19152397
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.